These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 1331649)

  • 1. Molecular dynamics of serotonin and ritanserin interacting with the 5-HT2 receptor.
    Edvardsen O; Sylte I; Dahl SG
    Brain Res Mol Brain Res; 1992 Jul; 14(3):166-78. PubMed ID: 1331649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular dynamics of the 5-HT1a receptor and ligands.
    Sylte I; Edvardsen O; Dahl SG
    Protein Eng; 1993 Sep; 6(7):691-700. PubMed ID: 8248092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular modeling of serotonin, ketanserin, ritanserin and their 5-HT2C receptor interactions.
    Kristiansen K; Dahl SG
    Eur J Pharmacol; 1996 Jun; 306(1-3):195-210. PubMed ID: 8813633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular dynamics of dopamine at the D2 receptor.
    Dahl SG; Edvardsen O; Sylte I
    Proc Natl Acad Sci U S A; 1991 Sep; 88(18):8111-5. PubMed ID: 1910173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allosteric properties of the 5-HT2 receptor system of the rat tail artery. Ritanserin and methysergide are not competitive 5-HT2 receptor antagonists but allosteric modulators.
    Frenken M; Kaumann AJ
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Apr; 335(4):359-66. PubMed ID: 3110629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular structure and dynamics of serotonin.
    Edvardsen O; Dahl SG
    Brain Res Mol Brain Res; 1991 Jan; 9(1-2):31-7. PubMed ID: 1850076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of the binding sites and selectivity of sarpogrelate, a novel 5-HT2 antagonist, to human 5-HT2A, 5-HT2B and 5-HT2C receptor subtypes by molecular modeling.
    Rashid M; Manivet P; Nishio H; Pratuangdejkul J; Rajab M; Ishiguro M; Launay JM; Nagatomo T
    Life Sci; 2003 May; 73(2):193-207. PubMed ID: 12738034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular modeling of antipsychotic drugs and G protein coupled receptors.
    Dahl SG; Edvardsen O; Sylte I
    Therapie; 1991; 46(6):453-9. PubMed ID: 1819151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential modes of agonist binding to 5-hydroxytryptamine(2A) serotonin receptors revealed by mutation and molecular modeling of conserved residues in transmembrane region 5.
    Shapiro DA; Kristiansen K; Kroeze WK; Roth BL
    Mol Pharmacol; 2000 Nov; 58(5):877-86. PubMed ID: 11040033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mapping the binding site pocket of the serotonin 5-Hydroxytryptamine2A receptor. Ser3.36(159) provides a second interaction site for the protonated amine of serotonin but not of lysergic acid diethylamide or bufotenin.
    Almaula N; Ebersole BJ; Zhang D; Weinstein H; Sealfon SC
    J Biol Chem; 1996 Jun; 271(25):14672-5. PubMed ID: 8663249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular modeling of the endogenous peptide Leu-Ser-Ala-Leu, pindolol, 5-hydroxytryptamine and their interactions with the human 5-hydroxytryptamine1B (5-HT1B) receptor.
    Kristiansen K; Edvardsen O; Dahl SG
    Recept Channels; 1998; 6(1):31-50. PubMed ID: 9664621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Site-directed mutagenesis of the serotonin 5-hydroxytrypamine2 receptor: identification of amino acids necessary for ligand binding and receptor activation.
    Wang CD; Gallaher TK; Shih JC
    Mol Pharmacol; 1993 Jun; 43(6):931-40. PubMed ID: 8316224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The structure of human serotonin 2c G-protein-coupled receptor bound to agonists and antagonists.
    Bray JK; Goddard WA
    J Mol Graph Model; 2008 Aug; 27(1):66-81. PubMed ID: 18499489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Excitatory responses to serotonin (5-HT) in neurons of the rat piriform cortex: evidence for mediation by 5-HT1C receptors in pyramidal cells and 5-HT2 receptors in interneurons.
    Sheldon PW; Aghajanian GK
    Synapse; 1991 Nov; 9(3):208-18. PubMed ID: 1776132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A highly conserved aspartic acid (Asp-155) anchors the terminal amine moiety of tryptamines and is involved in membrane targeting of the 5-HT(2A) serotonin receptor but does not participate in activation via a "salt-bridge disruption" mechanism.
    Kristiansen K; Kroeze WK; Willins DL; Gelber EI; Savage JE; Glennon RA; Roth BL
    J Pharmacol Exp Ther; 2000 Jun; 293(3):735-46. PubMed ID: 10869371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and structure-activity relationships of a new model of arylpiperazines. Study of the 5-HT(1a)/alpha(1)-adrenergic receptor affinity by classical hansch analysis, artificial neural networks, and computational simulation of ligand recognition.
    López-Rodríguez ML; Morcillo MJ; Fernández E; Rosado ML; Pardo L; Schaper K
    J Med Chem; 2001 Jan; 44(2):198-207. PubMed ID: 11170629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Theoretical models of interactions between buspirone analogues and 5-HT1A and 5-HT2A serotonin receptor subtypes.
    Bronowska A; Sylte I; Edvardsen Ø; Østensen R; Leś A; Chilmonczyk Z
    Acta Pol Pharm; 2000 Nov; 57 Suppl():40-5. PubMed ID: 11293260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the 5-HT2 receptor antagonist, ritanserin on hyperthermia and depletion of 5-HT in frontal cortex induced by a 5-HT releasing drug, p-chloroamphetamine (PCA) in mice.
    Yamada J; Sugimoto Y; Ohkura M; Inoue K
    Biol Pharm Bull; 2001 Oct; 24(10):1195-7. PubMed ID: 11642332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of chronic ritanserin and clorgyline administration on 5-HT2 receptor linked inositol phospholipid hydrolysis.
    Twist EC; Brammer MJ; Stephenson JD; Corn TH; Campbell IC
    Biochem Pharmacol; 1990 Nov; 40(9):2111-6. PubMed ID: 2122900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploration of the ligand binding site of the human 5-HT(4) receptor by site-directed mutagenesis and molecular modeling.
    Mialet J; Dahmoune Y; Lezoualc'h F; Berque-Bestel I; Eftekhari P; Hoebeke J; Sicsic S; Langlois M; Fischmeister R
    Br J Pharmacol; 2000 Jun; 130(3):527-38. PubMed ID: 10821780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.